{"meshTags":["Adenocarcinoma","Antineoplastic Agents","Carcinoma, Pancreatic Ductal","Cyclooxygenase 2 Inhibitors","Drug Delivery Systems","Humans","Inflammation","NF-kappa B","PPAR gamma","Pancreatic Neoplasms","Pancreatitis","Reactive Oxygen Species"],"meshMinor":["Adenocarcinoma","Antineoplastic Agents","Carcinoma, Pancreatic Ductal","Cyclooxygenase 2 Inhibitors","Drug Delivery Systems","Humans","Inflammation","NF-kappa B","PPAR gamma","Pancreatic Neoplasms","Pancreatitis","Reactive Oxygen Species"],"publicationTypes":["Comment","Evaluation Studies","Letter"],"title":"Novel drug targets based on association between inflammation and pancreatic ductal adenocarcinoma.","pubmedId":"20601821"}